Metropolis Healthcare Ltd will issue bonus shares in a 3:1 ratio on a record date of 20 March 2026, meaning shareholders will get 3 new shares for every 1 share held, with bonus equity credited on or before 23 March–3 April 2026, funded entirely from free reserves without any cash outflow.

Metropolis Healthcare 3:1 Bonus Issue – Key Facts

• Bonus ratio: 3:1 – three (3) new fully paid-up equity shares of face value ₹2 for every one (1) existing fully paid-up equity share of face value ₹2.

• Record date: Friday, 20 March 2026 – only shareholders on this date are eligible for bonus shares.
• Deemed date of allotment: Monday, 23 March 2026 (per SEBI circular); credit/dispatch expected on or before 3 April 2026.
• Pre‑bonus capital: 5,18,31,942 shares (₹2 FV) – paid-up capital ₹10.36 crore.​
• Post‑bonus capital: 20,73,27,768 shares (₹2 FV) – paid-up capital ₹41.46 crore, authorized capital unchanged at ₹63.86 crore.​
• Total bonus shares: 15,54,95,826 equity shares of face value ₹2 each; reserve utilization ~₹31.09 crore.​
• Source of funds: Securities Premium, General Reserve, Retained Earnings from audited FY25 accounts – no cash consideration to shareholders.​
• Q3 FY26 performance: Revenue ₹406 crore (+25.8% YoY), PAT ₹42 crore (+33.7% YoY), EBITDA ₹95 crore (+32.4% YoY), margin improved to 23.4%.

Illustration: If the stock is at ₹1,800 pre‑bonus and you hold 10 shares, after 3:1 bonus you will hold 40 shares and the price will theoretically adjust to around ₹450 – total value stays ~₹18,000 (ignoring market moves).

What 3:1 Bonus Means for Metropolis Shareholders

• Share count multiplies by 4: 3 extra shares for each existing share → holding becomes 4x in number, though total economic value remains same at the time of adjustment.​

• Price adjustment: Market price generally adjusts to ~¼ of pre‑bonus price on ex‑bonus date, but actual level depends on demand-supply and sentiment.​
• Liquidity boost: More free‑float shares often mean tighter spreads and higher trading volumes, making entry/exit easier for investors.
• No change in market cap: Bonus shares come from reserves; company valuation doesn’t change just because of the split of units.
• Signal of confidence: Management is using strong reserves (Securities Premium ₹24,926.52 lakh, General Reserve ₹2,987.38 lakh, Retained Earnings ₹94,702.25 lakh) to reward shareholders, indicating healthy balance sheet and growth visibility.

Strengths of Metropolis Healthcare Bonus Issue

• Strong reserves & net-debt-free status support the ₹31.09 crore reserve transfer without stressing the balance sheet.
• Q3 FY26 performance robust with 26%+ revenue growth and 52% PAT growth (ex‑exceptional); bonus aligns with earnings momentum.
• Improved EBITDA margin to ~23–25% shows operating leverage in diagnostics, backing management’s confidence to issue bonus shares.
• 3:1 bonus makes the stock more affordable on a per‑share basis post adjustment, aiding retail participation and liquidity.
• All bonus shares rank pari passu with existing shares for dividends and voting, ensuring no class differentiation for new units.​

Risks & Considerations Around the 3:1 Bonus

• No intrinsic value creation – bonus is cosmetic; business fundamentals and growth still drive long‑term returns, not the corporate action itself.
• EPS and per‑share ratios dilute mechanically as share count quadruples, so valuation multiples (P/E, EPS) must be re‑interpreted post bonus.
• Short‑term volatility likely around ex‑bonus and record date as traders rotate for bonus capture and profit‑booking..
• Higher free-float can increase speculation, making the stock more sensitive to news and quarterly results.​
• If growth slows after bonus, expanded equity base may cap per‑share earnings growth and pressure valuations, especially at rich multiples.

FAQs:-

1. What does Metropolis Healthcare’s 3:1 bonus issue mean for shareholders?
In a 3:1 bonus issue, Metropolis Healthcare will issue three additional fully paid-up shares for every one share you already hold. So if you own 10 shares before the record date, you will receive 30 extra shares, and your total holding will become 40 shares. The overall value of your investment does not change just because of the bonus; only the number of shares and the per‑share price adjust.

2. What is the record date for Metropolis Healthcare’s bonus issue and why is it important?
The record date for the 3:1 bonus issue is 20 March 2026. Only investors whose names appear in the company’s shareholder records (demat account) on this date will be eligible to receive the bonus shares. If you buy or sell close to this date, you need to ensure the trade is settled before the record date to qualify.

3. How will Metropolis Healthcare’s share price change after the 3:1 bonus issue?
After the ex‑bonus date, the market price will typically adjust to roughly one‑quarter of the pre‑bonus level, because your share count becomes four times. For example, if the stock trades around ₹1,800 before the bonus, it may adjust towards ₹450 after the bonus. However, the actual traded price will depend on market sentiment, demand-supply and broader conditions.

4. Does the 3:1 bonus issue make Metropolis Healthcare a better investment?
The bonus issue itself does not change the intrinsic value of the business or its future earnings potential. It improves liquidity and reduces the per‑share price, making the stock more accessible for smaller investors, but long‑term returns will still depend on Metropolis Healthcare’s growth in revenue, profits and cash flows, not on the bonus alone.

5. When will the Metropolis Healthcare bonus shares be credited to demat accounts?
Bonus shares are typically credited a few days after the record date, within the timeline mentioned in the company’s corporate action notice and exchange filings. Once credited, you will see the increased number of shares in your demat account, and all bonus shares will carry the same rights as your existing shares, including eligibility for future dividends and voting.